ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PACB Pacific Biosciences of California Inc

5.20
-0.33 (-5.97%)
After Hours
Last Updated: 19:56:48
Delayed by 15 minutes

Period:

Draw Mode:

Volume 7,256,225
Bid Price 5.20
Ask Price 5.27
News -
Day High 5.54

Low
4.97

52 Week Range

High
14.55

Day Low 5.18
Company Name Stock Ticker Symbol Market Type
Pacific Biosciences of California Inc PACB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.33 -5.97% 5.20 19:56:48
Open Price Low Price High Price Close Price Prev Close
5.50 5.18 5.54 5.19 5.53
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
38,196 7,256,225 $ 5.39 $ 39,109,434 - 4.97 - 14.55
Last Trade Time Type Quantity Stock Price Currency
19:58:29 13 $ 5.20 USD

Pacific Biosciences of California Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.39B 267.44M - 128.3M -314.25M -1.18 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Pacific Biosciences of C... News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No PACB Message Board. Create One! See More Posts on PACB Message Board See More Message Board Posts

Historical PACB Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.116.094.975.467,251,3250.091.76%
1 Month6.606.834.975.928,010,733-1.40-21.21%
3 Months8.2510.654.977.248,093,304-3.05-36.97%
6 Months11.5311.9554.977.636,225,761-6.33-54.90%
1 Year9.1014.554.979.114,961,103-3.90-42.86%
3 Years32.4137.423.8511.454,708,771-27.21-83.96%
5 Years7.3253.692.2012.093,815,934-2.12-28.96%

Pacific Biosciences of C... Description

Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the company's revenue is derived from North America, followed by Asia and Europe.

Your Recent History

Delayed Upgrade Clock